Genetic Technologies Limited (GTG.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 3.9 Million AUD | -35.06% |
| 2023 | 6.01 Million AUD | -7.12% |
| 2022 | 6.47 Million AUD | 2792.02% |
| 2021 | -240.47 Thousand AUD | -132.65% |
| 2020 | 736.43 Thousand AUD | 393.61% |
| 2019 | -250.82 Thousand AUD | -126.31% |
| 2018 | -110.83 Thousand AUD | -524.83% |
| 2017 | 26.08 Thousand AUD | -68.0% |
| 2016 | 81.52 Thousand AUD | -88.1% |
| 2015 | 685.25 Thousand AUD | -58.4% |
| 2014 | 1.64 Million AUD | 15.06% |
| 2013 | 1.43 Million AUD | -84.74% |
| 2012 | 9.38 Million AUD | -42.23% |
| 2011 | 16.24 Million AUD | 130.69% |
| 2010 | 7.04 Million AUD | 78.77% |
| 2009 | 3.93 Million AUD | -73.47% |
| 2008 | 14.84 Million AUD | 106.35% |
| 2007 | 7.19 Million AUD | 292.75% |
| 2006 | 1.83 Million AUD | -62.27% |
| 2005 | 4.85 Million AUD | 716.49% |
| 2004 | 594.57 Thousand AUD | -93.58% |
| 2003 | 9.26 Million AUD | -29.32% |
| 2002 | 13.1 Million AUD | 132.68% |
| 2001 | 5.63 Million AUD | 40.17% |
| 2000 | 4.01 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | -4.3 Million AUD | -171.66% |
| 2024 Q4 | 2.79 Million AUD | 0.0% |
| 2024 Q2 | -1.98 Million AUD | 0.0% |
| 2023 FY | 6.01 Million AUD | -7.12% |
| 2023 Q2 | -1.54 Million AUD | 0.0% |
| 2023 Q4 | -1.22 Million AUD | 0.0% |
| 2022 FY | 6.47 Million AUD | 2792.02% |
| 2022 Q4 | 2.92 Million AUD | 50.84% |
| 2022 Q1 | 1.16 Million AUD | 415.36% |
| 2022 Q2 | 741.18 Thousand AUD | -36.27% |
| 2022 Q3 | 1.93 Million AUD | 161.65% |
| 2021 Q3 | 652.86 Thousand AUD | 341.6% |
| 2021 Q2 | -270.22 Thousand AUD | 0.0% |
| 2021 Q4 | -368.79 Thousand AUD | -156.49% |
| 2021 FY | -240.47 Thousand AUD | -132.65% |
| 2020 FY | 736.43 Thousand AUD | 393.61% |
| 2020 Q2 | -206.07 Thousand AUD | 0.0% |
| 2020 Q4 | -144.88 Thousand AUD | 0.0% |
| 2019 FY | -250.82 Thousand AUD | -126.31% |
| 2019 Q4 | -278.12 Thousand AUD | 0.0% |
| 2019 Q2 | -61.27 Thousand AUD | 0.0% |
| 2018 Q4 | -54.7 Thousand AUD | 0.0% |
| 2018 FY | -110.83 Thousand AUD | -524.83% |
| 2018 Q2 | -56.13 Thousand AUD | 0.0% |
| 2017 Q2 | 72.98 Thousand AUD | 0.0% |
| 2017 Q4 | -46.89 Thousand AUD | 0.0% |
| 2017 FY | 26.08 Thousand AUD | -68.0% |
| 2016 FY | 81.52 Thousand AUD | -88.1% |
| 2016 Q4 | 45.49 Thousand AUD | 0.0% |
| 2016 Q2 | 36.02 Thousand AUD | 0.0% |
| 2015 Q4 | 401.48 Thousand AUD | 0.0% |
| 2015 FY | 685.25 Thousand AUD | -58.4% |
| 2015 Q2 | 283.77 Thousand AUD | 0.0% |
| 2014 Q4 | 1.04 Million AUD | 0.0% |
| 2014 FY | 1.64 Million AUD | 15.06% |
| 2014 Q2 | 603.11 Thousand AUD | 0.0% |
| 2013 Q3 | - AUD | 100.0% |
| 2013 Q4 | -197.07 Thousand AUD | 0.0% |
| 2013 FY | 1.43 Million AUD | -84.74% |
| 2013 Q2 | -771.03 Thousand AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 FY | 9.38 Million AUD | -42.23% |
| 2012 Q2 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 Q2 | - AUD | 0.0% |
| 2011 FY | 16.24 Million AUD | 130.69% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | 7.04 Million AUD | 78.77% |
| 2009 FY | 3.93 Million AUD | -73.47% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 Q4 | 3.33 Million AUD | -49.76% |
| 2008 FY | 14.84 Million AUD | 106.35% |
| 2008 Q1 | 4.42 Million AUD | -30.1% |
| 2008 Q2 | 3.65 Million AUD | -17.4% |
| 2008 Q3 | 6.63 Million AUD | 81.61% |
| 2007 Q4 | 6.32 Million AUD | 49.14% |
| 2007 FY | 7.19 Million AUD | 292.75% |
| 2007 Q3 | 4.24 Million AUD | 268.34% |
| 2007 Q2 | 1.15 Million AUD | -57.5% |
| 2007 Q1 | 2.7 Million AUD | 23.61% |
| 2006 Q4 | 2.19 Million AUD | -14.72% |
| 2006 FY | 1.83 Million AUD | -62.27% |
| 2006 Q1 | 3.37 Million AUD | 426.69% |
| 2006 Q2 | 2.84 Million AUD | -15.61% |
| 2006 Q3 | 2.56 Million AUD | -9.82% |
| 2005 Q3 | 3.55 Million AUD | 55.6% |
| 2005 Q1 | 3.76 Million AUD | 0.0% |
| 2005 Q4 | -1.03 Million AUD | -129.1% |
| 2005 FY | 4.85 Million AUD | 716.49% |
| 2005 Q2 | 2.28 Million AUD | -39.37% |
| 2004 FY | 594.57 Thousand AUD | -93.58% |
| 2003 FY | 9.26 Million AUD | -29.32% |
| 2002 FY | 13.1 Million AUD | 132.68% |
| 2001 FY | 5.63 Million AUD | 40.17% |
| 2000 FY | 4.01 Million AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Australian Clinical Labs Limited | 247.36 Million AUD | 98.422% |
| BCAL Diagnostics Limited | 3.09 Million AUD | -26.028% |
| Genetic Signatures Limited | -16.2 Million AUD | 124.1% |
| Healius Limited | 541.2 Million AUD | 99.279% |
| Imagion Biosystems Limited | -3.88 Million AUD | 200.55% |
| Integral Diagnostics Limited | 103.8 Million AUD | 96.239% |
| INOVIQ Ltd | -989.82 Thousand AUD | 494.462% |
| Microba Life Sciences Limited | -8.58 Million AUD | 145.495% |
| Monash IVF Group Limited | 85.5 Million AUD | 95.433% |
| Rhythm Biosciences Limited | -1.35 Million AUD | 387.65% |
| Sonic Healthcare Limited | 2.33 Billion AUD | 99.832% |